Real-world subcutaneous infliximab for inflammatory bowel disease: A systematic review and meta-analysis

被引：0
|
作者：
Chetwood, J. [1 ,2 ]
Tran, Y. [3 ]
Subramanian, S. [6 ]
Smith, P. [7 ]
Iborra Colomino, M. [8 ]
Buisson, A. [9 ]
Paramsothy, S. [1 ,2 ,4 ,5 ]
Leong, R. [1 ,2 ,4 ,5 ]
机构：
[1] Concord Repatriat Gen Hosp, Sydney, NSW, Australia
[2] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia
[3] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia
[4] Macquarie Univ Hosp, Dept Gastroenterol, Sydney, NSW, Australia
[5] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
[6] Cambridge Univ Hosp Fdn Trust, Dept Gastroenterol, Cambridge, England
[7] Royal Liverpool Hosp, Dept Gastroenterol, Liverpool, Merseyside, England
[8] La Fe Univ Hosp Valencia, Dept Gastroenterol, Valencia, Spain
[9] Univ Clermont Auvergne, Clermont Ferrand, France
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
218
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [1] Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Chetwood, John David
    Tran, Yvonne
    Subramanian, Sreedhar
    Smith, Philip J.
    Iborra, Marisa
    Buisson, Anthony
    Paramsothy, Sudarshan
    Leong, Rupert W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (09): : 1440 - 1449
  • [2] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    [J]. Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [3] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    [J]. JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [4] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    [J]. GASTROENTEROLOGY, 2018, 154 (01) : S82 - S82
  • [5] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 : S57 - S58
  • [6] Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
    Smith, Philip J.
    Fumery, Mathurin
    Leong, Rupert W.
    Novak, Kerri
    Dignass, Axel
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1143 - 1156
  • [7] Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
    Zheng, Dian-yu
    Wang, Yi-nuo
    Huang, Yu-Hong
    Jiang, Min
    Dai, Cong
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [8] Real World Treatment Persistence With Vedolizumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Demuth, Dirk
    Patel, Haridarshan
    Adsul, Shashi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S370
  • [9] SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY OF INFLIXIMAB BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Karavitaki, M.
    Kani, C.
    Deutsch, M.
    Markantonis, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S143 - S143
  • [10] Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease
    Omeed Alipour
    Alakh Gualti
    Ling Shao
    Bing Zhang
    [J]. BMC Gastroenterology, 21
12345